News
Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the ...
Gavin Newsom will weigh in on health care bills targeting insulin prices, insurance approvals that cause medical delays, and ...
Type 1 Diabetes (T1D) disrupts the flow of daily life. You don’t drive your kids to school because you fear losing control of your car. You plan school and work and socializing around insulin ...
Insulin is a critical, life-saving hormone for patients with type 1 diabetes and many with type 2 diabetes.
An automated insulin delivery system received FDA approval for adults with type 2 diabetes on insulin therapy, according to an industry press release. The FDA approved an expanded indication for the ...
The developed technology has been granted two Indian patents, and the findings of the research were published in journals, ...
Researchers at IIT-Guwahati have developed a novel method to produce human insulin utilizing Pseudomonas fluorescens, making ...
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.
(MENAFN- GlobeNewsWire - Nasdaq) The global insulin delivery system market is valued at approximately USD 19.18 billion in 2025 and is projected to nearly double, reaching around USD 38.09 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results